Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Chlorpromazine Together With Standard of Care in New Diagnosis of Glioblastoma

NCT05190315 is registered in ClinicalTrials.gov with Mohammed Milhem as lead sponsor.

NCT NCT05190315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05190315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Chlorpromazine Together With Standard of Care in New Diagnosis of Glioblastoma
Lead sponsor
Mohammed Milhem
Phase
Phase 1
Overall status
Completed
Start date
January 28, 2022
Completion date
July 28, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme